Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Echizen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 22, 2011
Crystallization and preliminary X-ray diffraction of the first periplasmic domain of SecDF, a translocon-associated membrane protein, from Thermus thermophilusYuka Echizen, Tomoya Tsukazaki, Naoshi Dohmae, et al.
Nature|May 13, 2011
Structure and function of a membrane component SecDF that enhances protein exportTomoya Tsukazaki, Hiroyuki Mori, Yuka Echizen, et al.
Bioorganic & Medicinal Chemistry|April 13, 2020
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2Ikumi Kuriwaki, Minoru Kameda, Hiroyuki Hisamichi, et al.
Bioorganic & Medicinal Chemistry|January 24, 2021
Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potencyIkumi Kuriwaki, Minoru Kameda, Kazuhiko Iikubo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 22, 2011
Crystallization and preliminary X-ray diffraction of the first periplasmic domain of SecDF, a translocon-associated membrane protein, from Thermus thermophilusYuka Echizen, Tomoya Tsukazaki, Naoshi Dohmae, et al.
Nature|May 13, 2011
Structure and function of a membrane component SecDF that enhances protein exportTomoya Tsukazaki, Hiroyuki Mori, Yuka Echizen, et al.
Bioorganic & Medicinal Chemistry|April 13, 2020
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2Ikumi Kuriwaki, Minoru Kameda, Hiroyuki Hisamichi, et al.
Bioorganic & Medicinal Chemistry|January 24, 2021
Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potencyIkumi Kuriwaki, Minoru Kameda, Kazuhiko Iikubo, et al.
Pageof 1